Letter

MS risk sharing scheme

Response from chair of scientific advisory committee

BMJ 2010; 341 doi: 10.1136/bmj.c3590 (Published 7 July 2010)
Cite this as: BMJ 2010;341:c3590

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Richard J Lilford, professor of clinical epidemiology1
  1. 1University of Birmingham, Birmingham B15 2TT
  1. r.j.lilford{at}bham.ac.uk

    As chair of the Scientific Advisory Committee (SAG) of the Multiple Sclerosis Risk Sharing Scheme, I strongly reject the suggestion that our advice is based on any considerations other than scientific rigour.1 Members of the Department of Health and of the four companies attend meetings with …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular